孙梦茹 王莉英 钱春艳 钱卿

    中图分类号 R95 文献标志码 A 文章编号 1001-0408(2018)17-2310-05

    DOI 10.6039/j.issn.1001-0408.2018.17.02

    摘 要 目的：为加强辅助用药的管控、促进医院合理用药提供参考。方法：介绍我院对辅助用药的管理措施，引入“辅助用药使用强度”至考核管理中，收集我院实施辅助用药管理前后的相关数据，以药占比、辅助用药使用强度、辅助用药使用金额等为指标进行比较以评价管理效果。结果：通过加强对辅助用药的管理，采取量化指标、考核到组、监测预警、超限停药、限量采购、医师培训等信息技术与行政干预等措施，我院辅助用药管理成效显著，2016年5月(开始实施管控)与2017年6月辅助用药金额分别为 1 943.92、540.57万元，药占比分别为39.90%、33.76%；与管控前比较，管控后各科室辅助用药使用强度下降比例达12.86%～86.32%，不合理用药问题数从639例(在535份病历中)下降到147例(在538份病历中)。结论：我院采取的加强辅助用药管控的措施，不仅减少了辅助用药的费用、降低了药占比，还促进了临床合理用药。

    关键词 辅助用药；管控措施；辅助用药使用强度；药占比

    ABSTRACT OBJECTIVE： To provide reference for strengthening the management and control of adjuvant drug， and improving the rational drug use. METHODS： The management measures of adjuvant drug in our hospital were introduced. A concept of “adjuvant drug use density” was introduced to assessment management， and then relevant data of our hospital was collected before and after the implementation of adjuvant drug management. The effects of management were evaluated using drug proportion， adjuvant drug use density and cost of adjuvant drug as indexes. RESULTS： The significant achievement in our hospital was obtained through technological and administrative intervention as strengthening adjuvant drug management ......